Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma

Gastric adenocarcinoma of the fundic gland type (GAFG) and pyloric gland adenoma (PGA) have recently been recognized as rare types of neoplasia. We performed comparative immunohistochemical and genetic analyses of 3 GAFGs and 12 PGAs. All of the 3 GAFGs were diffusely positive for pepsinogen‐I, MIST1 and MUC6, indicating the predominantly chief cell/mucous neck cell differentiation of these tumors. A small number of H.K‐ATPase‐positive parietal cells were also scattered. PGAs invariably exhibited diffuse MUC6 and TFF2 expression, consistent with the pyloric gland differentiation of these tumors. Ten of the 12 PGAs also unexpectedly exhibited focal expression of pepsinogen‐I and MIST1, suggesting that PGAs often show focal chief cell differentiation and phenotypically resemble mucous neck cells rather than pyloric glands. The mutation analyses revealed activating GNAS mutations, which have been reported to be frequently detected in PGAs, in two of the GAFGs. While GAFGs and PGAs are morphologically distinct lesions, our observations showed their partially overlapping immunohistochemical profiles and shared presence of GNAS mutations, in addition to their common occurrence in the fundic gland mucosa. Based on these observations, we suggest that both GAFGs and PGAs are closely related lesions characterized by a mucous neck cell/chief cell lineage phenotype.

[1]  H. Tsuda,et al.  Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum , 2013, The Journal of pathology.

[2]  E. Montgomery,et al.  Gastric Adenocarcinoma With Chief Cell Differentiation: A Proposal for Reclassification as Oxyntic Gland Polyp/Adenoma , 2012, The American journal of surgical pathology.

[3]  Jason M Doherty,et al.  Tumorigenesis and Neoplastic Progression The Transcription Factor MIST 1 Is a Novel Human Gastric Chief Cell Marker Whose Expression Is Lost in Metaplasia , Dysplasia , and Carcinoma , 2010 .

[4]  A. Iwashita,et al.  Gastric Adenocarcinoma of Fundic Gland Type (Chief Cell Predominant Type): Proposal for a New Entity of Gastric Adenocarcinoma , 2010, The American journal of surgical pathology.

[5]  E. Montgomery,et al.  Pyloric Gland Adenoma: An Entity Distinct From Gastric Foveolar Type Adenoma , 2009, The American journal of surgical pathology.

[6]  Mark J. Miller,et al.  The gastric epithelial progenitor cell niche and differentiation of the zymogenic (chief) cell lineage. , 2009, Developmental biology.

[7]  N. Yoo,et al.  Absence of GNAS and EGFL6 mutations in common human cancers. , 2008, Pathology.

[8]  W. Chung,et al.  Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission , 2007, Pituitary.

[9]  J. Mills,et al.  The maturation of mucus-secreting gastric epithelial progenitors into digestive-enzyme secreting zymogenic cells requires Mist1 , 2007, Development.

[10]  M. Vieth,et al.  Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach , 2006, Gastric Cancer.

[11]  E. Montgomery,et al.  Biopsy interpretation of the gastrointestinal tract mucosa , 2006 .

[12]  S. Fujita,et al.  Tritiated thymidine autoradiographic study on cellular migration in the gastric gland of the golden hamster , 1976, Cell and Tissue Research.

[13]  C. Capella,et al.  Electron immunocytochemical localization of pepsinogen I (PgI) in chief cells, mucous-neck cells and transitional mucous-neck/chief cells, of the human fundic mucosa , 2004, Histochemistry.

[14]  M. Vieth,et al.  Pyloric gland adenoma: a clinico-pathological analysis of 90 cases , 2003, Virchows Archiv.

[15]  R. Poulsom,et al.  The mucous neck cell in the human gastric corpus: a distinctive, functional cell lineage , 1999, The Journal of pathology.

[16]  윤호주,et al.  Structural and Functional Study of Yer067w, a New Protein Involved in Yeast Metabolism Control and Drug Resistance , 2010, PloS one.

[17]  H. Bourne,et al.  GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.